Vaccine Insights, Год журнала: 2023, Номер 02(08), С. 309 - 316
Опубликована: Авг. 23, 2023
Fast and effective testing is a critical part of pandemic preparedness response; however, during the COVID-19 pandemic, there have been major disparities in access to diagnostic tests.Here, we outline barriers progress toward equitable diagnostics highlight important lessons learned for future.
Язык: Английский
BMJ Global Health, Год журнала: 2024, Номер 9(11), С. e017090 - e017090
Опубликована: Ноя. 1, 2024
Язык: Английский
Процитировано
1
The Lancet, Год журнала: 2023, Номер 401(10380), С. 884 - 886
Опубликована: Март 1, 2023
Язык: Английский
Процитировано
3
Microorganisms, Год журнала: 2023, Номер 11(8), С. 1963 - 1963
Опубликована: Июль 31, 2023
Anti-SARS-CoV-2 vaccines have played a pivotal role in reducing the risk of developing severe illness from COVID-19, thus helping end COVID-19 global public health emergency after more than three years. Intriguingly, as SARS-CoV-2 variants emerged, individuals who were fully vaccinated did get infected high numbers, and viral loads those unvaccinated. However, even with loads, significantly less likely to develop illness; this begs question whether main effect anti-SARS-CoV-2 is confer protection against or immunity infection. The answer consequential, not only understanding how work, but also efforts existing novel pathogens. In review, we argue that immune system sensitization-desensitization rather sterilizing may explain vaccine-mediated when load high. Through lessons learned make case disease’s aftermath, agencies must revisit healthcare policies, including redefining term “vaccine effectiveness.”
Язык: Английский
Процитировано
3
PLOS Global Public Health, Год журнала: 2024, Номер 4(10), С. e0003714 - e0003714
Опубликована: Окт. 17, 2024
Язык: Английский
Процитировано
0
Journal of Responsible Innovation, Год журнала: 2024, Номер 11(1)
Опубликована: Ноя. 27, 2024
COVID-19 crisis reaffirmed the power of a few companies to scale up production for mRNA vaccines, which created injustice as nations in developed world benefited first from available while LMICs waited at back queue. Initiatives such South Africa tech transfer hub sought address these concerns. The article engages an analysis different visions that underpin current vaccine innovation system and hub. I argue dominant vision global scalability by pharmaceutical are 'too big fail' limits transformative potential propose ways responsible governance coordination can some failings system.
Язык: Английский
Процитировано
0
Can J Public Health, Год журнала: 2023, Номер 114(2), С. 229 - 230
Опубликована: Фев. 28, 2023
Язык: Английский
Процитировано
1
BMJ, Год журнала: 2023, Номер unknown, С. p743 - p743
Опубликована: Апрель 6, 2023
Язык: Английский
Процитировано
0
The Lancet, Год журнала: 2023, Номер 401(10385), С. 1340 - 1340
Опубликована: Апрель 1, 2023
The pharmaceutical industry delivered billions of safe and effective COVID-19 vaccines at speed but, as highlighted by Els Torreele colleagues,1Torreele E Kazatchkine M Liu J et al.Stopping epidemics when where they occur.Lancet. 2023; 401: 324-328Summary Full Text PDF PubMed Scopus (10) Google Scholar these did not reach lower-income countries quickly enough. Science delivered, but the equity challenge not. To acknowledge this, we supported calls for greater sharing vaccines.2International Federation Pharmaceutical Manufacturers AssociationsFive steps to urgently advance vaccine equity.https://ifpma.org/news/five-steps-to-urgently-advance-covid-19-vaccine-equity/Date: May 19, 2021Date accessed: March 15, 2023Google authors' proposal goes against lessons learnt from ignoring current innovation ecosystem that worked this pandemic is needed tackle future ones. This nurtured decades research was instrumental in response, such mRNA vaccines, if up-ended (unnecessarily), it highly improbable commitments 100 Days Mission can be achieved.3International AssociationsBiopharmaceutical collaborates on implementation G7 improve readiness pandemics.https://ifpma.org/news/biopharmaceutical-industry-collaborates-on-the-implementation-of-the-g7-100-days-mission-to-improve-readiness-for-future-pandemics/Date: Dec 3, Policies adopted pandemics should evidence based. facts are science worked, immediate pathogens collaboration resulting hundreds partnerships voluntary technological transfer.4International AssociationsApplying learned create a healthier, safer, more equitable world.https://ifpma.org/publications/applying-lessons-learned-from-covid-19-to-create-a-healthier-safer-more-equitable-world/Date: 22, 2022Date focus challenges led inequitable rollout–vaccine nationalism need diverse manufacturing. Lessons have guided an response developed developing manufacturers biotechnologies.5International AssociationsBiotechs, pharma unite behind G20 offering practical solution better access pandemics.https://ifpma.org/news/biotechs-developing-countries-vaccine-manufacturers-and-pharma-unite-behind-a-proposal-to-g20-and-g7-offering-a-practical-solution-for-better-access-to-vaccines-for-future-pandemics/Date: Oct 23, We propose set aside, real time, percentage tools allocation susceptible populations low-income countries. If world leaders join forces, could roadmap new social contract builds response. I declare no competing interests. Stopping occurThroughout pandemic, other health reached out-of-step with demand.1–3 Yet address inequities catalysing fundamental changes required.4 Similarly, despite well known risk Ebola virus disease outbreaks, took months before candidate were made available testing during outbreak Uganda late 2022.5 And although there been cases mpox (formerly monkeypox) Nigeria, Democratic Republic Congo, Central African many years, only spread globally 2022 high-income focused disease, people wealthy getting therapies. Full-Text
Язык: Английский
Процитировано
0
Vaccine Insights, Год журнала: 2023, Номер 02(08), С. 309 - 316
Опубликована: Авг. 23, 2023
Fast and effective testing is a critical part of pandemic preparedness response; however, during the COVID-19 pandemic, there have been major disparities in access to diagnostic tests.Here, we outline barriers progress toward equitable diagnostics highlight important lessons learned for future.
Язык: Английский
Процитировано
0